SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-16-015275
Filing Date
2016-11-18
Accepted
2016-11-18 17:01:39
Documents
7
Period of Report
2016-11-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 74140
2 ex2-1.htm EX-2.1 387739
3 ex4-1.htm EX-4.1 42244
4 ex10-1.htm EX-10.1 89392
5 ex10-2.htm EX-10.2 24497
6 ex99-1.htm EX-99.1 14221
7 image_001.jpg GRAPHIC 2227
  Complete submission text file 0001493152-16-015275.txt   637215
Mailing Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021
Business Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021 4259083600
Marina Biotech, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-13789 | Film No.: 162008424
SIC: 2834 Pharmaceutical Preparations